Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program

JAMA Intern Med. 2020 Jun 1;180(6):915-916. doi: 10.1001/jamainternmed.2020.1260.

Doris Auth^{1

2

3

4}, Judy Staffa^{3

4

5}, Cynthia LaCivita^{1

2

3

4}

¹ Division of Risk Management, US Food and Drug Administration, Silver Spring, Maryland.
² Office of Medication Error Prevention and Risk Management, US Food and Drug Administration, Silver Spring, Maryland.
³ Office of Surveillance and Epidemiology, US Food and Drug Administration, Silver Spring, Maryland.
⁴ Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
⁵ Public Health Initiatives, US Food and Drug Administration, Silver Spring.

No abstract available

Publication types